MIA-PaCa-2（人胰腺癌細(xì)胞）
MIA-PaCa-2（人胰腺癌細(xì)胞）
- 貨號:
- NCL-10146
- 規(guī)格:
- ＞5×10^5 cells/T25培養(yǎng)瓶（凍存管）
- 目錄價:
- ￥1200.00
產(chǎn)品信息：
參考資料：
細(xì)胞STR檢測圖譜：
細(xì)胞樣品分型結(jié)果：
參考文獻(xiàn)：
【1】Kishimoto S, Brender JR, Chandramouli GVR, Saida Y, Yamamoto K, Mitchell JB, Krishna MC. Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy. Antioxid Redox Signal. 2021 Oct 10;35(11):904-915. doi: 10.1089/ars.2020.8131. Epub 2020 Sep 15. PMID: 32787454; PMCID: PMC8568781.
【2】Tan Y, Li X, Tian Z, Chen S, Zou J, Lian G, Chen S, Huang K, Chen Y. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Biochem Pharmacol. 2021 Jul;189:114085. doi: 10.1016/j.bcp.2020.114085. Epub 2020 Jun 6. PMID: 32522594.
【3】Wang X, Almoallim HS, Cui Q, Alharbi SA, Yang H. In situ decorated Au NPs on chitosan-encapsulated Fe3O4-NH2 NPs as magnetic nanocomposite: Investigation of its anti-colon carcinoma, anti-gastric cancer and anti-pancreatic cancer. Int J Biol Macromol. 2021 Feb 28;171:198-207. doi: 10.1016/j.ijbiomac.2020.12.037. Epub 2020 Dec 10. PMID: 33310102.
